Moderna stock jumps on positive data for cancer vaccine

78,827 次觀看・1 個月前

Shares of Moderna (MRNA) are moving up on Tuesday afternoon after the company released positive data for its individualized cancer vaccine tested in combination with Merck's Keytruda (MRK). The vaccine aims to train patients' immune systems to recognize and attack specific mutations in cancer cells. 

Yahoo Finance Anchors Josh Lipton and Julie Hyman break down Moderna's recent trial data.

For more expert insight and the latest market action, click here to watch this full episode of Market Domination.

Editor's note: This article was written by Nicholas Jacobino